CJC-1295 No DAC + Ipamorelin (10mg)
Dual GHRH/Ghrelin-Receptor Research Blend
A fixed 5mg + 5mg formulation combining Mod GRF 1-29 with ipamorelin for laboratory study of two growth-hormone secretagogue pathways.
Research Applications & Benefits
- 5mg Mod GRF 1-29 + 5mg Ipamorelin
- Dual-pathway research reagent
- GHRH-R and GHS-R signaling
- Fixed 1:1 formulation
What is CJC-1295 No DAC + Ipamorelin Blend?
CJC-1295 No DAC + Ipamorelin Blend is a catalog research material in the growth hormone category. The listed strengths describe total vial contents for laboratory research.
Listed vial contents: 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Mod GRF 1-29 acts at the GHRH receptor while ipamorelin acts at the ghrelin receptor (GHS-R1a). Combining them permits study of convergent pituitary signaling, but constituent activity does not establish clinical benefit or safety for the blend.
What are the research questions?
- GHRH-R and GHS-R pathway interaction studies
- Pituitary cell-signaling research
- Comparison with either constituent alone
What does the published work describe?
The pathways and individual compounds are documented; evidence specific to this commercial fixed-ratio formulation is limited.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Raun K et al. Eur J Endocrinol. 1998;139:552-561
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- CJC-1295 No DAC + Ipamorelin Blend
- CAS Number
- Mixture
- Molecular Weight
- Mixture
- HPLC Purity Specification
- ≥99% each
- Category
- Growth Hormone
- Starting Price
- $69.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
CJC-1295 No DAC + Ipamorelin Blend carries the purity specification shown above. Where a lot-specific CertikLabs Certificate of Analysis is available, the product page links its HPLC purity, LC-MS identity, and concentration results.
Frequently Asked Questions
Is CJC-1295 No DAC + Ipamorelin Blend suitable for human consumption?
No. CJC-1295 No DAC + Ipamorelin Blend is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is CJC-1295 No DAC + Ipamorelin Blend?
CJC-1295 No DAC + Ipamorelin Blend carries a ≥99% each HPLC purity specification. Check the product page for an available lot report.
How is CJC-1295 No DAC + Ipamorelin Blend shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
